Pharma

Ahmedabad, May 22:  Torrent Pharmaceuticals Limited today reported a strong base growth in the Fourth Quarter of last financial year 2025-26, driven by robust branded performance across key markets. Key Highlights for Q4 FY26:…
Read More...

New Delhi, May 6: Top Indian companies have committed investments to the tune of $20.5 billion in the United States at a Business Summit -- '2026 SelectUSA Investment Summit' -- in Maryland. The commitments span key sectors including…
Read More...

New Delhi, Mar 28: India and Sri Lanka should enhance cooperation in sectors like healthcare, pharmaceuticals, wellness, infrastructure, and trade. This was the thrust of the visit by a high-level business and institutional delegation of…
Read More...

Ahmedabad, March 21: Torrent Pharmaceuticals has launched Semaglutide brands - Sembolic and Semalix - in India, expanding the company’s presence in metabolic disorders such as type-2 diabetes and obesity. These medicines will be available…
Read More...

Mumbai, Feb 23: Torrent Group has launched a Diagnostics vertical, marking its entry into healthcare services. Operations have commenced with the start of a National Reference Laboratory in Navi Mumbai, the company said in a statement.…
Read More...

Ahmedabad, Feb 13: Torrent Pharmaceuticals Limited today announced its financial results for the third quarter of FY 26. Key Highlights for Q3 FY26: Revenue at Rs. 3,303 crores, up by 18% YoY Op. EBITDA* at Rs.1,088 crores, up by…
Read More...